Cargando empresa
Just reported
From Insulet's results release of 4 de noviembre de 2026; its quarterly report has since been filed.
Actual
842M US$
+19 % y/y
+5,0 % q/q
Guided
—
No guide given
Actual
2,03 US$
+64 % y/y
+48 % q/q
Guided
—
No guide given
Actual
189,8M US$
+61 % y/y
+46 % q/q
Guided
—
No guide given
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
The full earnings report →The themes Insulet is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
MDTMedtronic plc129,2B US$A+
SYKStryker Corp.118,9B US$A+
EWEdwards Lifesciences Corporation60,9B US$A+
GEHCGE Healthcare Technologies Inc.37B US$A
GKOSGlaukos Corp14,6B US$ARose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
DHRDanaher Corporation21 oct 2026CBGraded C, now B
MCKMckesson Corporation4 nov 2026BAGraded B, now A
CVSCVS Health Corp4 nov 2026BAGraded B, now AEWEdwards Lifesciences Corporation4 nov 2026BAGraded B, now A
BIIBBiogen Inc.28 oct 2026BAGraded B, now AEstados financieros completos →
Construido a partir de los propios informes de Insulet Corporation ante la Comisión de Bolsa y Valores de EE. UU. (SEC). Las cifras son las declaradas, con el historial por acción reexpresado a la base de acciones de hoy. Esto describe un negocio: no es asesoramiento de inversión ni una recomendación de compra o venta.
Grade C+
La franja bajo el precio muestra la calificación en cada fecha, calculada solo con los informes ya públicos en ese momento.
Mostrando 2 de 41 trimestres del historial de calificaciones de Insulet Corporation. Los otros 39 llegan hasta noviembre de 2016.
